Vanguard Group Inc Regenxbio Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,421,192 shares of RGNX stock, worth $27.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,421,192

Previous 3,472,988 1.49%

Holding current value

$27.7 Million

Previous $24.8 Million 13.11%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$5.31 - $10.4 $275,036 - $538,678	-51,796 Reduced 1.49%	3,421,192 $28.1 Million
Q1 2025 May 09, 2025	BUY	$5.92 - $8.7 $2.88 Million - $4.24 Million	487,036 Added 16.31%	3,472,988 $24.8 Million
Q4 2024 Feb 11, 2025	SELL	$7.23 - $11.56 $10 Million - $16 Million	-1,383,039 Reduced 31.66%	2,985,952 $23.1 Million
Q3 2024 Nov 13, 2024	SELL	$10.49 - $14.39 $7.81 Million - $10.7 Million	-744,791 Reduced 14.56%	4,368,991 $45.8 Million
Q2 2024 Aug 13, 2024	BUY	$11.51 - $21.53 $2.73 Million - $5.1 Million	236,901 Added 4.86%	5,113,782 $59.8 Million
Q1 2024 May 10, 2024	BUY	$12.17 - $24.61 $5.31 Million - $10.7 Million	436,043 Added 9.82%	4,876,881 $103 Million
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $828,375 - $1.34 Million	64,265 Added 1.47%	4,440,838 $79.7 Million
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $601,300 - $730,254	36,531 Added 0.84%	4,376,573 $72 Million
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $396,651 - $499,785	23,021 Added 0.53%	4,340,042 $86.8 Million
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $805,048 - $1.09 Million	44,527 Added 1.04%	4,317,021 $81.6 Million
Q4 2022 Feb 10, 2023	BUY	$20.4 - $24.73 $101,020 - $122,462	4,952 Added 0.12%	4,272,494 $96.9 Million
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $339,231 - $533,273	15,219 Added 0.36%	4,267,542 $113 Million
Q2 2022 Aug 12, 2022	BUY	$19.35 - $35.04 $3.52 Million - $6.37 Million	181,861 Added 4.47%	4,252,323 $105 Million
Q1 2022 May 13, 2022	BUY	$24.62 - $34.31 $406,131 - $565,977	16,496 Added 0.41%	4,070,462 $135 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $1.35 Million - $1.8 Million	44,784 Added 1.12%	4,053,966 $133 Million
Q3 2021 Nov 12, 2021	BUY	$29.09 - $45.68 $1.9 Million - $2.99 Million	65,423 Added 1.66%	4,009,182 $168 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $40.48 $128 Million - $160 Million	3,943,759 New	3,943,759 $153 Million

Others Institutions Holding RGNX

# of Institutions

181

Shares Held

45.1M

Call Options Held

103K

Put Options Held

100K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $350M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Regenxbio Inc. Transaction History